Tumor Embrionik Sistem Saraf Pusat
Abstract
Keywords
Full Text:
PDFReferences
Blessing, M. M., & Alexandrescu, S. (2020). Embryonal Tumors of the Central Nervous System: An Update. Surgical Pathology Clinics, 13(2), 235–247. https://doi.org/10.1016/j.path.2020.01.003
Essianda, V. (2023). Brain Tumor: Molecular Biology, Pathophysiology, and Clinical Symptoms. Jurnal Biologi Tropis, 23(4), 260–269. https://doi.org/10.29303/jbt.v23i4.5585
Gajjar, A. (2020). Recent Advances in the Treatment of Medulloblastoma: Focus on Chemotherapy and Radiation Therapy. Neuro-Oncology, 22(5), 741–749.
Jiang, S. (2021). Long-term Cognitive and Emotional Outcomes in Pediatric Brain Tumor Survivors. Journal of Clinical Oncology, 39(2), 151–159.
Kram, D. E., Henderson, J. J., Baig, M., Chakraborty, D., Gardner, M. A., Biswas, S., & Khatua, S. (2018). Embryonal tumors of the central nervous system in children: The era of targeted therapeutics. Bioengineering, 5(4), 78. https://doi.org/10.3390/bioengineering5040078
Lacruz, C. R. (2024). Central nervous system tumors: Diagnostic pathology. Springer. https://doi.org/10.1007/978-3-031-51078-6
Lagerwaard, L., & Jalal, M. (2017). Genetic causes of medulloblastoma. Nature Reviews Neurology, 13(7), 412–422.
Louis, D. N. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System. Acta Neuropathologica, 131(6), 803–820.
Orr, B. A. (2020). Pathology, diagnostics, and classification of medulloblastoma. Brain Pathology, 30(3), 664–678. https://doi.org/10.1111/bpa.12837
Packer, R. J., & McNeil, J. A. (2022). Medulloblastoma and other embryonal tumors. In Principles and Practice of Pediatric Neurosurgery (pp. 371–390). Springer.
Pajares, M. (2020). Immunotherapy in CNS Tumors: From Bench to Bedside. Journal of Neuro-Oncology, 148(1), 31–42.
Reddy, A. T. (2020). Efficacy of High-Dose Chemotherapy and 3-D Conformal Radiation for Atypical Teratoid / Rhabdoid Tumor: A Report from the Children’s Oncology Group Trial. Journal of Clinical Oncology, 38(11), 117. https://doi.org/10.1200/JCO.19.01776
Thompson. (2016). Prognostic value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: a Retrospective Integrated Clinical and Molecular Analysis. The Lancet Oncology, 17(4), 484–495. https://doi.org/10.1016/S1470-2045(15)00581-1
Wahyuhadi, J., Pratama, M. F. R., Wathoni, R. T. Z., & Basuki, H. (2021). The Indonesian central nervous system tumors registry (Ina-CTR): 7 years result from single institution of primary brain tumor epidemiology. Indonesian Journal of Neurosurgery, 4(1), 25–35. https://doi.org/10.15562/ijn.v4i1.142
Yao, Y. (2017). Surgical Outcomes and Prognostic Factors for Pediatric CNS Embryonal Tumors. Neurosurgical Review, 44(3), 441–448.
Zhang, X. (2019). Targeted Therapy for Medulloblastoma: Inhibition of Hedgehog Signaling. Frontiers in Oncology, 9, 614.
DOI: https://doi.org/10.51849/j-p3k.v6i4.834
Refbacks
- There are currently no refbacks.







